Mutabilis SA
Batiment 2C 2nd Floor
156, rue de Vaugirard
Paris
75015
France
Tel: 33-0-140615330
Website: http://www.mutabilis.com/
6 articles with Mutabilis SA
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
-
Novo Holdings REPAIR Impact Fund Invests USD 12 million in Mutabilis and IBT Vaccines and provides strategic update
1/6/2020
The Novo Holdings REPAIR Impact Fund announced a EUR 7 million investment in Mutabilis, a company developing novel antibacterials against Gram-negative infections based near Paris, France.
-
Mutabilis Joins The European ENABLE Consortium To Fight Antibiotic Resistance
10/18/2017
Mutabilis announces its selection by the European ENABLE project (European Gram-negative Antibacterial Engine), which aims to improve the development of antibiotics against infections caused by multiresistant Gram-negative bacteria.
-
Biocitech SAS: Mutabilis Receives EUR Four Million of EU Funding for Its HIVINNOV Project
9/18/2012
-
Stefan Fischer Appointed CEO of Mutabilis
5/20/2008
-
French Anti-Infectives Developer Mutabilis Takes $9.6M Second Round
6/15/2004